Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We disagree with the recommendation by the World Health Organization to use Xpert(®) MTB/RIF on cerebrospinal fluid for the initial diagnosis of tuberculous meningitis (TBM). TBM is a devastating disease requiring empirical treatment even when the probability of disease is low. We suggest that a useful TBM diagnostic test needs a negative predictive value (NPV) of ⩾ 99% so that empirical treatment can be stopped safely. The NPV of Xpert is around 84%, making a negative test of limited value. While better tests are awaited, a composite score, possibly combining Xpert with clinical variables and with high NPV, should be constructed and validated prospectively.

Original publication

DOI

10.5588/ijtld.14.0805

Type

Journal article

Journal

Int J Tuberc Lung Dis

Publication Date

03/2015

Volume

19

Pages

276 - 277

Keywords

Antibiotics, Antitubercular, Cerebrospinal Fluid, Humans, Molecular Diagnostic Techniques, Mycobacterium tuberculosis, Nucleic Acid Amplification Techniques, Predictive Value of Tests, Sensitivity and Specificity, Specimen Handling, Tuberculosis, Meningeal